23 results
SC TO-T/A
EX-99
KNTE
Kinnate Biopharma Inc
19 Mar 24
Third party tender offer statement (amended)
4:44pm
markets or equity price levels or trading volumes), in each case, in the United States, the European Union or elsewhere in the world, (C) any change
SC TO-T
EX-99
KNTE
Kinnate Biopharma Inc
4 Mar 24
Third party tender offer statement
5:24pm
, the European Union or elsewhere in the world, (C) any change in applicable Law or GAAP after the date hereof, (D) geopolitical conditions, the outbreak
8-K
EX-2.1
KNTE
Kinnate Biopharma Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
exchange rates, credit markets or equity price levels or trading volumes), in each case, in the United States, the European Union or elsewhere in the world … bargaining or similar Contracts with any labor union, labor organization, or works council to which the Company or its subsidiaries are a party or by which
S-3ASR
EX-1.2
nf15 hb6cn7f
3 Jan 22
Automatic shelf registration
8:51am
10-Q
vrfomv14obeptybjj2w
17 May 21
Quarterly report
4:26pm
10-K
kgex0ce
29 Mar 21
Annual report
4:26pm
424B4
z9rph2 79
3 Dec 20
Prospectus supplement with pricing info
4:48pm
S-1/A
71ggs64yybx3t7axo
30 Nov 20
IPO registration (amended)
6:05am
S-1/A
EX-1.1
x8bd1rgp yx86um3
30 Nov 20
IPO registration (amended)
6:05am
S-1
5smzwt3
13 Nov 20
IPO registration
5:03pm